Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression
- 14 February 2025
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 766, 110344
Abstract
No abstract availableKeywords
This publication has 210 references indexed in Scilit:
- Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiformeCancer Medicine, 2021
- Inactivation of the glutathione peroxidase GPx4 by the ferroptosis‐inducing molecule RSL3 requires the adaptor protein 14‐3‐3εFEBS Letters, 2019
- GPX4 at the Crossroads of Lipid Homeostasis and FerroptosisProteomics, 2019
- Hsp70: A Cancer Target Inside and Outside the Cell2017
- Selenium and Selenocysteine in Protein ChemistryAngewandte Chemie International Edition, 2017
- Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotypeInternational Journal of Cancer, 2017
- The brain tumor microenvironmentGlia, 2011
- Microarray‐based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progressionInternational Journal of Cancer, 2004
- Structural Organization of the Human Selenium-Dependent Phospholipid Hydroperoxide Glutathione Peroxidase Gene (GPX4): Chromosomal Localization to 19p13.3Biochemical and Biophysical Research Communications, 1998
- Efficient Reduction of Lipoamide and Lipoic Acid by Mammalian Thioredoxin ReductaseBiochemical and Biophysical Research Communications, 1996